Scholars Central

OpinionPublished 25 Mar 2022

General Therapeutics for HIV

Authors: Mohammed amin akbar khan

HIV: Current Research

Volume 7 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

As a result of the HIV epidemic's acceleration, is now the leading cause of mortality for HIV-positive people worldwide, accounting for 22% (350,000) of all HIV-related fatalities worldwide. Of the 8.8 million incident cases of HIV reported worldwide in 2010, 1.1 million affected HIV-positive individuals . There is now convincing evidence that treating HIV patients concurrently, as opposed to starting Antiretroviral (ARV) medications after HIV treatment is finished, lowers mortality. Because of this, cotreatment has become the norm for the majority of patients. Although 6 months of combination therapy are still necessary for the treatment of drug-sensitive HIV, there are methods being researched and must be evaluated among patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in HIV: Current Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHIV: Current Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Mohammed amin akbar khan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels